Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 7, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder: A Randomized Clinical Trial.

Penny Ping Qin1, Minxia Jin1,2, Rebecca Laidi Kan1

  • 1Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China.

JAMA Network Open
|July 6, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing Interpersonal Difficulties in Digital Communication in Psychotherapy for Adults With Chronic Depression.

American journal of psychotherapy·2026
Same author

Lifetime and acute risk of suicidality by profiles of early life adversity: an observational cohort study in a high-risk population.

Scientific reports·2026
Same author

Cognitive effects of transcranial random noise stimulation in schizophrenia: A triple-blind randomized placebo-controlled pilot study.

Journal of psychiatric research·2026
Same author

Using a functional near-infrared spectroscopy-guided brain-computer interface to facilitate observational imitation after stroke.

Annals of physical and rehabilitation medicine·2026
Same author

How Standardized Is Transcranial Magnetic Stimulation Treatment for Depression? Large-Cohort Modeling Reveals Systematic Dosimetric Variability.

Psychotherapy and psychosomatics·2026
Same author

Adverse childhood experiences and risk of non-mental medical diseases in adulthood: an umbrella review.

EClinicalMedicine·2026
This summary is machine-generated.

Transcranial pulse stimulation (TPS) demonstrated antidepressant effects in a randomized clinical trial for major depressive disorder. This novel noninvasive brain stimulation technique showed significant improvements and modulated brain circuits, suggesting therapeutic potential.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Technology

Background:

  • Transcranial pulse stimulation (TPS) is an emerging noninvasive brain stimulation technique.
  • Preliminary evidence suggests TPS may have antidepressant effects.
  • However, rigorous testing in double-blind, sham-controlled randomized clinical trials was lacking.

Purpose of the Study:

  • To evaluate the antidepressant efficacy of TPS in patients diagnosed with major depressive disorder (MDD).

Main Methods:

  • A 2-arm, parallel-design, double-blind, sham-controlled randomized clinical trial was conducted.
  • Eighty participants with MDD (Hamilton Depression Rating Scale score ≥14) were randomized to receive 12 sessions of active or sham TPS targeting the left dorsolateral prefrontal cortex.
  • The primary outcome measure was the change in Montgomery-Åsberg Depression Rating Scale (MADRS) score after 12 sessions.

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Related Experiment Videos

Last Updated: Jul 7, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Main Results:

  • The active TPS group showed a statistically significant greater reduction in MADRS scores compared to the sham group (mean difference: -4.19, P=.048).
  • Resting-state fMRI revealed that active TPS significantly enhanced functional connectivity within the left dorsolateral prefrontal cortex and its connections with other brain regions implicated in depression.
  • The treatment was found to be safe and well-tolerated.

Conclusions:

  • Transcranial pulse stimulation is a safe and well-tolerated treatment for major depressive disorder.
  • TPS demonstrates antidepressant effects and modulates key brain circuits involved in depression.
  • Further research is warranted to optimize TPS efficacy through increased sessions and refined targeting.